coronary-artery-disease | Media Room

Press Release Sep 5, 2024

Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis

Press Release Oct 15, 2020

Heparin Market Growth Predicted at Over 6.6% Through 2026: Global Market Insights, Inc.

Major heparin market players include Amphastar Pharmaceutical, Sanofi, Hepalink group, Pfizer, Leo Pharma, and Laboratorios Farmaceuticos Rovi SA.

Press Release May 28, 2012

Odessa's Healthy Heart Center Celebrates Ten Years of Helping Heart Patients Live Active, Symptom-Free Lives with the Assistance of Non-Invasive EECP® Therapy

Healthy Heart's medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center's patients

Press Release May 9, 2012

Advanced Heart Disease Patient Regains Lost Energy, Attends 50-Year Class Reunion After Receiving EECP® Therapy at Heart House in Washington Township

Dr. Scott Fertels says non-invasive treatment boosts blood flow to the heart, relieves chest pain, and improves energy and mobility for about 80 percent of patients with symptomatic coronary artery disease

Press Release Dec 18, 2011

Glendale Heart Patient Trades Angina Pain and Shortness of Breath for Long Walks on the Beach After EECP® Therapy

New, Non-invasive Outpatient Procedure for Treating Heart Disease Available at the Office of Dr. Don W. Lee Improves Vascular Health and can Reduce Symptoms Associated with Coronary Artery Disease for Three to Five Years

Press Release Aug 9, 2011

Neograft Technologies, Inc. Closes $5 Million Equity Offering

Neograft Technologies, Inc., a medical device company developing advanced cardiac technologies for use in heart bypass procedures, announced successful completion of a $5 Million equity offering on July 29, 2011.